micafungin
Selected indexed studies
- Micafungin. (Drugs, 2004) [PMID:15101786]
- Echinocandins Pharmacokinetics: A Comprehensive Review of Micafungin, Caspofungin, Anidulafungin, and Rezafungin Population Pharmacokinetic Models and Dose Optimization in Special Populations. (Clin Pharmacokinet, 2025) [PMID:39707078]
- Micafungin. (Ann Pharmacother, 2004) [PMID:15340133]
_Worker-drafted node — pending editorial review._
Connections
micafungin is a side effect of
Sources
- Echinocandins Pharmacokinetics: A Comprehensive Review of Micafungin, Caspofungin, Anidulafungin, and Rezafungin Population Pharmacokinetic Models and Dose Optimization in Special Populations. (2025) pubmed
- Micafungin. (2004) pubmed
- Micafungin. (2004) pubmed
- Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial. (2016) pubmed
- Micafungin: a therapeutic review. (2004) pubmed
- Micafungin: the US perspective. (2005) pubmed
- Micafungin injection for the treatment of invasive candidiasis in pediatric patients under 4 months of age. (2022) pubmed
- Micafungin for the treatment of invasive aspergillosis. (2014) pubmed
- Clinical Pharmacokinetics and Pharmacodynamics of Micafungin. (2018) pubmed
- Micafungin-Induced Hypoglycemia in a Patient With Type 1 Diabetes: A Case Report and Review of Literature. (2019) pubmed